Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvin Chen

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Human Gene Therapy|November 25, 2020
Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman PrimatesDouglas J Ballon, Jonathan B Rosenberg, Edward K Fung, et al.
Oncogenesis|July 23, 2025
Targeting SLC7A5 in lung squamous cell carcinoma: implications for cancer metabolism shift and boron neutron capture therapy resistanceYen-Ju Lin, Yu-Cheng Wu, Yu-Jui Liu, et al.
Journal of Neurology|October 21, 2025
Outcomes of GLP-1 receptor agonist use following ischemic stroke: a propensity score-matched real-world analysisPranjal Rai, Girish Bathla, Niharika Praveen, et al.
Respiratory Medicine|June 26, 2026
GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Propensity Score-Matched Real-World AnalysisPranjal Rai, Girish Bathla, Niharika Praveen, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 30, 2026
GLP-1 receptor agonists and post-endovascular thrombectomy outcomes in acute ischemic stroke: a multicenter propensity score matched analysisPranjal Rai, Girish Bathla, Niharika Praveen, et al.
Human Gene Therapy. Clinical Development|February 8, 2018
AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's DiseaseJonathan B Rosenberg, Michael G Kaplitt, Bishnu P De, et al.
AJNR. American Journal of Neuroradiology|June 2, 2026
Glucagon-Like Peptide-1 Receptor Agonist Exposure and Long-Term Outcomes in Patients with Asymptomatic Carotid Stenosis: A Propensity Score-Matched Real-World AnalysisPranjal Rai, Girish Bathla, Eishvauk Aggarwal, et al.
Human Gene Therapy|May 11, 2023
Identification of Safe and Effective Intravenous Dose of AAVrh.10hFXN to Treat the Cardiac Manifestations of Friedreich's AtaxiaCarlos Munoz-Zuluaga, Monica Gertz, Melissa Yost-Bido, et al.
Aging Cell|July 16, 2020
Aging shifts mitochondrial dynamics toward fission to promote germline stem cell lossOyundari Amartuvshin, Chi-Hung Lin, Shao-Chun Hsu, et al.
Neurology International|May 26, 2026
Association of Glucagon-like Peptide-1 Receptor Agonist Use with Stroke and Mortality Outcomes in Asymptomatic Intracranial Atherosclerotic Disease: Propensity Score-Matched Real-World AnalysisPranjal Rai, Daniel Mandel, Girish Bathla, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Human Gene Therapy|November 25, 2020
Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman PrimatesDouglas J Ballon, Jonathan B Rosenberg, Edward K Fung, et al.
Oncogenesis|July 23, 2025
Targeting SLC7A5 in lung squamous cell carcinoma: implications for cancer metabolism shift and boron neutron capture therapy resistanceYen-Ju Lin, Yu-Cheng Wu, Yu-Jui Liu, et al.
Journal of Neurology|October 21, 2025
Outcomes of GLP-1 receptor agonist use following ischemic stroke: a propensity score-matched real-world analysisPranjal Rai, Girish Bathla, Niharika Praveen, et al.
Respiratory Medicine|June 26, 2026
GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Propensity Score-Matched Real-World AnalysisPranjal Rai, Girish Bathla, Niharika Praveen, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 30, 2026
GLP-1 receptor agonists and post-endovascular thrombectomy outcomes in acute ischemic stroke: a multicenter propensity score matched analysisPranjal Rai, Girish Bathla, Niharika Praveen, et al.
Human Gene Therapy. Clinical Development|February 8, 2018
AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's DiseaseJonathan B Rosenberg, Michael G Kaplitt, Bishnu P De, et al.
AJNR. American Journal of Neuroradiology|June 2, 2026
Glucagon-Like Peptide-1 Receptor Agonist Exposure and Long-Term Outcomes in Patients with Asymptomatic Carotid Stenosis: A Propensity Score-Matched Real-World AnalysisPranjal Rai, Girish Bathla, Eishvauk Aggarwal, et al.
Human Gene Therapy|May 11, 2023
Identification of Safe and Effective Intravenous Dose of AAVrh.10hFXN to Treat the Cardiac Manifestations of Friedreich's AtaxiaCarlos Munoz-Zuluaga, Monica Gertz, Melissa Yost-Bido, et al.
Aging Cell|July 16, 2020
Aging shifts mitochondrial dynamics toward fission to promote germline stem cell lossOyundari Amartuvshin, Chi-Hung Lin, Shao-Chun Hsu, et al.
Neurology International|May 26, 2026
Association of Glucagon-like Peptide-1 Receptor Agonist Use with Stroke and Mortality Outcomes in Asymptomatic Intracranial Atherosclerotic Disease: Propensity Score-Matched Real-World AnalysisPranjal Rai, Daniel Mandel, Girish Bathla, et al.
Pageof 6